
Global Trial Accelerators™
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech and Biopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
What You’ll Learn:
- Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
- Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
- Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.
Why Listen?
- Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
- Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
- Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.
“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.
This podcast is why we partnered with them.”
– Digital Health Startup CEO
New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.
Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Global Trial Accelerators™
Widy Medina, CEO & Co-Founder at Telebionix
Widy is the Co-Founder and CEO of two technology companies with vast experience ranging from robotics, product design, fabrication, and automation to the electronic assembly of consumer products, food and beverage tech, biotech, medical devices, and pharmaceutical industries. Widy spent 40+ years living in Puerto Rico, and 20+ supporting pharmaceutical, biotechnology, and medical device companies with a presence in multiple Latin American locations. He led an automation firm that exposed him to FDA regulations, manufacturing, and compliance during that time. Today, he leads a medical device company with a unique RPM product to capture biomarkers and allow those to be maintained in a safe digital format for exchange with healthcare professionals or as a personal health tracking system.
Welcome to the Latin MedTech Leaders podcast, a conversation with MedTech leaders who have succeeded or plan to succeed in Latin America. Please subscribe on your favorite podcasting platform. Apple Podcast, Spotify, Google Podcast. Amazon Music is teacher. Tune in. I heard radio, Pandora, or these are
Speaker 2:Welcome to the Latin MedTech Leaders podcast, a conversation with leaders who have succeeded or plan to succeed in Latin America. Today our guest is Wii Medina, co-founder and CEO at teleios, the company developing the remote sense, the first all in one biometric device for personal monitoring and telehealth power by artificial intelligence to measure multiple biomarkers such as SPO two, heart rate, blood pressure, body temperature, ecg, and its pH scope. Widy has a track record of success of companies like Tesla, motors, C Board, and others. So, Widy, I'm really, really delighted to have you here in the show. Welcome.
Speaker 3:Thank you. Thank you for having me, Julio. I'm, um, super glad to share, uh, a a very beautiful morning with you,
Speaker 2:<laugh>. Excellent. All right, Widy, so let's get started with your journey. How is it that you got to where you are today? I know you are from Puerto Rico, you're a personal, uh, link and, and involvement with Latin America, but, uh, uh, tell us about it.
Speaker 3:You know, holy, I'm still trying to understand that myself. How did I end up here?<laugh>, it's, uh, I mean, uh, it's, it's, it's such a, I don't know. It's such a road that, that I travel. Um, and then, and yeah, I'll be more than happy to share humble beginnings, uh, like you said, from, uh, from Puerto Rico, um, family that has been, uh, working very hard, um, second generation of, uh, of, uh, higher education. Um, so, you know, we are, we're that kind of family that's trying to, to come up in the, in the, in the, in the ranks to see what we can do in society to help. Um, I, it started, started with, uh, with something that was as distance as you can imagine to, to healthcare. Our family business was a machine shop, so that's the very basics of, of industrial support. Right. Um, so we started a, a small machine shop operation in Puerto Rico. Um, I, um, as, as every, as every, uh, young, young kid, right. My dad kicked me out and say, go ahead and get some, some, uh, higher education. I came back from, uh, from Georgia Tech with, uh, um, ideas of, uh, crazy ideas of automation, crazy ideas of robotics. And, and I was very lucky to, to have a, you know, receptive family that said, yeah, let's, let's grow with it. Right? Let's grow with it. So we did.
Speaker 2:And so, but yes, for the audience, I mean, to come out of Latin America and get accepted to Georgia touch, that's quite an accomplishment. Yeah. Language barrier. The cultural barrier, the cost involve on all that. And the, the vision. The vision,
Speaker 3:It was a, it was a burden to the family. Thank you. It was a burden to a family was, uh, it was, uh, a great experience. Like I said, you come back with, uh, ideas that, that, that, you know, everything in the world, right. Uh,<laugh> and how far away from the truth. But anyway, you, you<laugh> you apply those ideas, like I said, very receptive, uh, uh, um, parents and, and family overall. They, they accepted the, the new craziness and, and we, uh, we were able to convert the machine shopping to an automation house. Right. Wow. So, so that was, that was incredible and incredible achievement. After a couple of years, uh, um, working, and I say a couple, not to mention like 20 or so, uh, working there, um, I, that's as expected, you know, I, I rose the ranks from sweeping the, sweeping the floors, paying my dues
Speaker 2:<laugh> Yeah.
Speaker 3:From sweeping the floors to managing the company at some point, um, we, uh, we decided to sell the company. Uh, we sold it to the employees, and the employees are, are, are today running the company, which is a beautiful thing. Um, so, so that was, that was a great experience there. And, uh, and then I move and pursue a, a opportunity in, uh, New York, um, company called, um, universal Instruments. And they are focused on, uh, electronics assembly for high speed assembly for electronics and automation for electronics. Um, that gave me, that gave me such a view of, of, uh, technology and teams, uh, around the world, right? Like you said, um, um, Tesla, um, I worked there as a, as a contractor for they're very lucky to, to, um, to spend a lot of time, uh, developing some production lines for them. Then the same thing for, for Apple, which kind of pushed me, um, about four years going back and forth between, um, China and, and us.
Speaker 2:Interesting.
Speaker 3:Yeah. Extremely interesting. That was, that was such an, you know, eye opening experience, not only personally Julio, but, but, um, professionally, you know, you get to see the, the, the, uh, the great design, um, of, of wearables, the great design of, of, uh, high tech, right?
Speaker 2:That's a peak of human
Speaker 3:Exactly.
Speaker 2:Technology and innovation and design.
Speaker 3:Yeah, exactly. And then, and then get to get, to go to the contract manufacturers and, and not only come with that design idea, but then implement, right. Implement, uh, design for manufacturing, help manufacture a couple of their products, um, in, in a very competitive environment. Um, that, that really was the, the, the, the university, I would say, of life, right? That was, that was, I think where I really learned a lot. Um, uh, the true engineering was, was applied and learned there. Um, and, and it opened doors, it opened doors to, um, to meaning the team that I have today, to engaging with people that, that, that had the same mindset. Um, and, and eventually we found ourself, um, in the, uh, in the pandemic situation, and everything got shifted, right? Um, when we got to that, to that position and, and, and everything just stopped for everybody in the world, we had the opportunity to, to discuss, uh, among the team and, uh, and find what can we do to help, right? What, what can we do that is different? And that's how Teleios and resins are born from, from answering that particular question, which I know eventually in this conversation we're gonna touch more on.
Speaker 2:Sure. Yeah. Excellent. Uh, wi fascinating journey. I mean, I, I, I totally understand, uh, where you're coming from and the struggle that we have to sometimes go through from Latin America to jump to, to, to the places where you are now. So,<laugh> again, congratulations. I'm very proud of, uh, being in contact with you today.
Speaker 3:Thanks.
Speaker 2:Thank you. All right. So Willie, let's talk about, uh, Latin America a little bit. Let's talk about the region. Let's talk about trends. Uh, what do you see happening in Latin America that is relevant to our discussion today about, um, commercialization and innovation of medical technologies?
Speaker 3:I think that when we talk about Latin American, we need to talk about culture, and then we talk about everything. We're unique. We, we are definitely unique, and, and it doesn't matter if you're from Argentina, but as Colombia oli from, uh, include Mexico and all central American, right? It, it's, we, we are unique. We are unique in a sense that we are extremely passionate about what we do. That being from politics, social sports,<laugh>, business, whatever you think about, we in that, in America, I have, I've been lucky to, to travel the world and, and every Latin culture, it's the same. We're extremely passionate. And that's, that's, I would like to start there because that definitely defines the rest of the conversation. Um, I, I see Latin American as a, as a true land of opportunity right now. The, it's, it's, it's really a land of opportunity, and it depends on, on, on people in, in the positions like where I find myself today to make sure that we make the best out of that, right? Um, um, we have the res we cannot continue to, to, uh, chief the responsibility of the future of Latina American to politics, to, um, um, to, to, um, the, the social thing. We need to have people that are in positions of, of that can help, that can impact to looked at Latino-American as a true opportunity and then add value to it, not, not only take value from it, right? Which, which has been a historical downfall of the purpose in Latin-American, but to add value to it. So, so, uh, I think that, that, like I said, seeing it as a line of opportunity is, is key, um, people that, uh, that are in, in management positions that can see the opportunity to, to create, to create markets, to design markets, to, to open markets, right? The, the difference from before, before the pandemic is that, um, the, the overall world market was apparently understood by everybody, right? And, and Latin America was, was kind of not at the forefront of what was happening globally right now, when after the pandemic situation, I think that the complete understanding of how world and global economics works, it is just shifted completely. And I think that Latin America has an opportunity to become one of the major players in that. I mean, the richness of the people that are, are in, in their, of the technical knowledge that it's in, in Latin America, um, the, the opportunities that, that the governments are, are now opening, right? To, to allow companies like mine to come in and, and, and truly work together developing, uh, opportunities. That's why I said Latin America, we need to look at it as, as some, some fertile ground where we can define new markets for healthcare for, for, um, you know, automation, robotics from tech, high tech, uh, technical, um, um, um, applications from different types of manufacturing. So it's not only in, in, in my current vertical that it's the health healthcare vertical, but overall, it's, it's a key area to focus on. That's how I see it. That's how I see in America today.
Speaker 2:Yeah. Yeah. Willy, I, I agree with that a hundred percent. Um, I think the region is maturing or has mature now. Yeah. Is, is ready for the world. It's ready, it's ready. Be plane. You got it.
Speaker 3:Yeah. Yeah. You got it. It is ready now. Go ahead. That definitely you hit the, the, the nail on the head when you say the maturity, right? Um, um, I think that the, regardless of, of, of, of politics, regardless of everything else, the social maturity, now, it's there, right? The, the professional, um, base ground that you need to create the infrastructure, right, to create the, the, the markets to create the opportunity is there, right? And it's not only one country. It is not only one section in Latin America and the whole, the whole area. It's now more cohesively ready to do that. There will always be differences, there will always be differences in opinion, but the focus of seeing the, the area as a, as, as, like I said, again and again, line of opportunity. Now it's the time.
Speaker 2:Yes. Yes. Uh, and you can see that with the, the impact. You can see that with, uh, the, um, Pacific Alliance. Not so much with mer se, unfortunately, but, uh, the Indian pack. I'm, I'm, I'm so happy to see the progress they're making. And for listeners, the Indian pack is the trade block of the Indian countries, Columbia, uh, Peru, Bolivia, ECU War. And Venezuela, of course, is not part of it for obvious reasons, but it's, it's an Indian country that used to be part of the Indian pack. But now there's, and this is news. I mean, this just happened last month. There is free circulation of people. Uh, there is, uh, recognition of academic, um, titles, I mean, diplomas, uh, you can move freely with just one ID card, uh, among all these countries. You can live in Peru tomorrow if you're a Colombian. If you are any Corian, you can live in Bolivia tomorrow without any immigration rate tape or anything. So that says a lot about what these countries are, are doing together to, to move ahead. And in terms of regulatory, um, homogenization, they are putting together for cosmetics and for fruit products, the same set of requirements and everything. And eventually, if you get approval in Bolivia, you're gonna get a regulatory approval in Peru or equator dramatically. So, and that's fantastic. Eventually we'll go to drugs and medical devices and, and the Pacific Alliance is something similar. And in terms of the Pacific Alliance, you have O E C D countries, Chile, Mexico, Columbia. Correct. Uh, Costa Rica just became an O E C D member in May. So the region is maturing.
Speaker 3:It's, it's, it's showing that, and, and all of this was due 40 years, but I'm so glad to see it happening. Right. I'm so glad to finally see that step. Um, because it works. I mean, when, when countries decide to, to join forces to work together, to, to agree on basic terms of, of trade ship, basic terms of, of, you know, um, um, professional exchange of, of, uh, you know, it, it, it really, it really sets the, the base cement to, to create something wonderful. So, so that's, that's the, again, to to continue with the same sentence line of opportunity, people seeing that, working towards that, government's working towards that. And, and yes, like you said, the in the impact opens to, to things outside of my vertical market, but I see a, I see light at the end of the tunnel, right? The US as, as the lead in my company, instead of saying, oh, they forgot about the, the, the medical device. No, no, that's coming because it, it, it just makes sense, right?
Speaker 2:Yeah, exactly. It
Speaker 3:Makes sense. So I'm so glad to see it starting.
Speaker 2:Yeah. Because one of the problems of the region really is a fragmentation. The region has over 600 million people is double the size and probably more than the population in the United States. But you have 33 countries, different, uh, regulatory pathways, et cetera, et cetera, different markets. So it's about time that we get our act together. We all get together in the same bus, not different bosses,<laugh>, we all get together in the same bus going to the same place, because we'll, going to the same place, eventually we'll want progress and, and, and to have, uh, the best for our citizens.
Speaker 3:We definitely, as a Latino, I identify with that. I, I want the region to, to pro to progress. I want the, the region to have the opportunity to show, to show what it can do. Cause I know what it can do. We just need to show the world what it can do. Right. Exactly.
Speaker 2:And, and, and one of the, the major problems that we're gonna address, uh, uh, in a second with your product and everything, is that patients in Latin America have delayed access to medical innovation. It will probably be 10, 15 years between a product is approved in the United States or Western Europe, and that product, and the time that that product is available, uh, to, uh, a, a patient in Puerto Rico or in Peru and Ecuador. And that's sad. I mean, that's fair.
Speaker 3:Completely.
Speaker 2:It's the same product. It's just a matter of having somebody look the other way and say, Hey, there are, there's a marketing in Colomb, Peru, and Chile. Yep. And patients need this too. I mean, they all get
Speaker 3:Sick. Same humans. Same
Speaker 2:Humans. Same humans. Exactly.
Speaker 3:Humans same
Speaker 2:Needs.
Speaker 3:Yeah. Yeah. And I agree with that. And, and, and that's why I said that, that people, people that are in, in, in very, um, unique positions, like the one that I find myself is, is our responsibility, especially, especially Latino, uh, uh, uh, uh, people that, that find themselves in, in, in, in places of power. And I hate to use that, that word, but it's, it's truly what it is in places of power to, to make it happen, right?
Speaker 2:Where you can influence this issue,
Speaker 3:You can influence the situation. You can work with the governments, you can work with the entities, you can work with the hospitals, with the, with the distributors, with the everybody that is in that supply chain of solutions. Right?
Speaker 2:And also, I'm sure maybe wrong, but correct me if I'm wrong, but I'm sure the minority of your team, the board of directors, the investors, people you work with are white Anglos, or primarily white Anglos, and they don't have the same passion and same knowledge about the potential of Latin America that you have. So if you can show them that that's in itself, uh, uh, uh, a a again, for
Speaker 3:A, in a lot of these cases, if not almost every case, it's, it's not that they don't want to, it's they don't understand, right? They, they, they understand it because they have never been exposed to it. So, so it's not, it's not their fault, it's their fault of the circumstances that are around them, right. That, that surrounds them. So, so when you start talking about the, the opportunities, passion opening about, you know, there's the true chance to, to, to not only, not only make great business, but also helps the, the area overall, which in terms the whole continent is, is the, all the all three, uh, uh, of the major areas in, in Americas, we'll, we'll gain out of that, right? Um, so, um, so when they, when they hear me, uh, passionately talk about the, the culture opportunity and the possibilities, um, in Latin America, slowly they start to understand, right? Um, and, and, and the language that is universal is when you bring numbers to the table, right? When you start bringing numbers to the tables, then, then everything makes sense, right? Then they were like, exactly, yeah. Why didn't I heard about this before? It's like, well, cause we didn't give you the opportunity,
Speaker 2:Right? Yeah. Yeah. That's true. That's a, that's a great way to put it. I like, I like that<laugh>. I like that. Yeah. Yeah. All right. So let's talk about what you're doing today. Uh, Widy. Uh, let's talk about your, your company, your product, what problem you are addressing, you're solving, and how can patients in Latin America benefit from it?
Speaker 3:Oh, great question. Um, like I said at the beginning, right? What are the pandemic, um, um, with everybody from themselves, you know, at a hope enough time to start thinking and to start, um, reviewing your decisions up to this point, and, and making sure you, that you make good, good decisions for the future, right? So, so it was, um, it was a very difficult time, but at the same, at the same time, it gave, um, a lot of us the opportunity to hone in what are we gonna do, right? Um, in, in, in my personal case, um, it was, uh, transformational, right? Uh, uh, it hit me personally. Um, we, we lost, uh, uh, people, um, um, close family members. We, we, we, we found ourself, you know, with, with family members struggling, with, with, uh, being, being in, in a confined space, we found ourself not having access to, to healthcare, um, in a, in a reasonable way. Um, everybody's scared about going directly to, to, uh, to get the, the, at least even even basic checkups, right? Um, um, um, ladies that, that, uh, pregnant, uh, ladies that, that were afraid to go and, and check, check themselves the regular checkups. Um, you know, um, the same thing with, uh, geriatric patients, the same thing with, I mean, it, we saw it all, right? So the team got together, we started interviewing, um, to understand better interviewing the, uh, the, uh, first responders, the people in the front lines, the, the doctors working, um, with, with the situation. They, they were the ones feeling the situation. And luckily, we had a couple of minutes of the time, and, and after hundreds of interviews, I mean, hundreds of interviews, uh, Julio, it was crazy. Um, it, no, it, it was, it was crazy. But people were so, so hit and, and, and so, uh, in a, in a new space that, that they were willing to talk to us just because they wanted to bend on what situations they were having. So it was very easy to get, to get these people that were working 20 hours, 24 hours, you know, on on, on Sundays continuously to even spare an hour of their time to tell us what, what was wrong with the system at that point, what they were seeing that was new, right? Um, and, and what we found out is that if we gave the, the healthcare providers, the, the, and when I say providers is institutions, people, doctors, nurses, first responders, er people, the, the, the, the, you know, everybody in that if we gave them a, a tool that can allow them to interact with patients remotely, um, that will give them the opportunity to manage, to triage, to, to, to use resources better, right? The first resource being themselves, and then everything else that gets, gets attached to that, right? Um, so, so Teleios was born out of, out of all of those interviews and a, a common ground, we need to solve the current telehealth and telemedicine approach. We need to improve it. We need to allow remote patient monitoring best, the, the best possible way. There is a, there is an opportunity to do a product that yes, it will definitely, uh, um, generate, generate revenue. That's great. But that can impact society, right? So to have that opportunity is kind of, we, we saw it at once, once in a lifetime, right? How many people have the opportunity to say, we're gonna start a business, by the way, where can impact every life in the globe with this product? I mean, that's an amazing thing to say, right? So that's Ramsen, ramens been our first, uh, medical product. And what we did is we filled the gap that is, is currently assisting in, in your telehealth consultation or remote patient monitoring consultation. As of today, it was what we had today, a great conversation, uh, via video, video call. And that's what we have. And, and, and, and that is great. But if you are the doctor, and I'm your patient, and I'm telling you all this information, you're, you're there thinking, gosh, if I had the data, right, not only what he's telling me, the, the biometric data, right? To back up the, what I'm, what I'm sensing from this conversation, right? And that is what exactly we provided. We provided, like you mentioned at the beginning, a device is capable of, of, uh, uh, sensing a lot of your vital signs, right? We call them biometrics. Um, so s p two or, or the same thing as, as, uh, blood oxygen levels, um, the body temperature, the, uh, uh, your digital stethoscope, which is an incredible feat just to, to have that there, right? And then, um, we are also taking heart rate, and we're also, uh, making sure that we have cost costless blood pressure. I mean, that, that, on its own, that's
Speaker 2:Quite an innovation. That's a breakthrough.
Speaker 3:Great breakthrough.
Speaker 2:Even think Apple is working on that.
Speaker 3:It's a, it's a, well, and, and, and, you know, I have a lot of respect for that team because I, I work with that team for a long time. So, so, you know, my hats off. I know what they're capable of. Uh, we have the, the advantage that we're picking up the information where it's best to pick up, right? And that's giving us a little bit of an edge.
Speaker 2:Okay? And they, they can only pick it
Speaker 3:From here. Exactly. They, I see right now they have it here. We're picking the information exactly where, where we can take advantage of that, of that position in the body. Um, and, and, and yeah, we, we, we work very hard. Um, usually a product like this, Julio, takes about two and a half years, or, or, or even three years to, to develop and put together. I cannot stress enough that, that my, my teams are either mean just, or special forces, or I don't know what they are, but they are an amazing team that put this together in about 10 months, I mean, in about 10 months with every test, with every process, with everything that, that, that we could do, um, to confirm that, that we were going in the right direction. Today, we ended up with an mvp. We went through a proof of concept. We have a minimum viable product today working store that, that, uh, FDA approval and, uh, possibly I
Speaker 2:Thinking,
Speaker 3:Right? Yeah. And, and five 10 K, that's correct. Uh, is a class to the ui. It's, uh, non-invasive. We're going focused on that, on that ul and, and see Mark, I mean, we're, we're super focused right now to comply with, uh, with the regulatory, um, agencies and put this in every home that we can't, um, it, it, it will be good business, but it will be a game changer in how countries can provide for their people the healthcare that is needed. That that's, I mean, that's a powerful statement when you have a, you know what I mean? It's, it's a powerful statement.
Speaker 2:Yeah. Especially in Latin America, where you have these remote locations in the jungle, in the mountains, even in cities. I mean, Bogota is a metropolitan area of 10 million people and traveling, the traffic is hell. So people are stuck in their neighborhoods or their houses and, and, and, and the best care is not necessarily where they are. So That's right. Its, that's right. The cell. And there's a saying, now the cell is a new clinic.
Speaker 3:Yeah.
Speaker 2:<laugh> the cell is a new clinic. So if you have devices like this close to where people live, I mean, ideally in their houses, but, uh, I don't know if that's gonna be possible or not, but, uh, at, at a, at a certain, at a location close to their house where they can walk to and have access to medical care,
Speaker 3:And even that, we, we want to go at every house because we want to make sure that people can tend not only themselves, but their families, and give them
Speaker 2:Sure. Give
Speaker 3:Them, I want to want access to premium healthcare service. That is not a a, that's not a luxury, that is a human. Right. And we need to work for that. We need to give everybody the human right of getting good healthcare. Right. And you say Latin American, just real quick, um, in the us in the us, 47% of the people in us, 47% of the people live in rural areas away from healthcare.
Speaker 2:That's a good way to put it. Yeah.
Speaker 3:So, I mean, it's, they're not in any, in any advantage in this thing. We're all in this together.
Speaker 2:They have the same problem go that far to Peru, to
Speaker 3:They have the same problem. They're not far from Bogota, they not from Argentina. It's the same problem. People Yes. 53% work are are in cities with, with an overcrowded city, by the way. But then you have 47% that, that are 20 miles plus away from the closest, uh, medical services.
Speaker 2:That's true. That's true. Yeah. Yeah. Regardless, even if you're in a major urban area, you still wanna be at home with your family. I mean, you are, between Zoom calls, everybody's working remotely. I mean, the,
Speaker 3:The convenience, right?
Speaker 2:The, the, the thought of getting out in your car, waiting for the doctor to come to you in a waiting room, in a hospital, in a small clinic, I mean, yeah. And
Speaker 3:It's easy for us, uh, Julio, it's easy for us because it will be that for us, it will be for us will be sitting on a car, going there sitting.
Speaker 2:Yeah. We have an option. So people don't even have that option.
Speaker 3:Imagine those that do not, and imagine those that have very, uh, very delicate health conditions that if they go to these offices, they get exposed to other things that they shouldn't. Right. Um, like I said, in geriatrics, in the case of my dad, I wish I had this already solved, um, before my dad passed away, because my mother, which she, she's all, that's my dad, you know, 74 years old. And, and, and, you know, taking my dad was a, a a, an Alzheimer patient. And, and as, as everybody knows, as soon as you take a patient like that and, and you put them on a, on a new environment, the, the, it's so difficult to manage a patient. Imagine for a 74 year old to manage a patient that is seeing himself completely lost. Right. Just to get a regular biometric checkup, check your pressure, check your temperature,
Speaker 2:Come on. Yeah. Yeah. You don't have to travel half an hour, an hour and go through that, or be to Right.
Speaker 3:Take, there are alternatives. And we, and we have the technology for that.
Speaker 2:That's true. That's true. And, you know, we, another trend going back to Latin America, another trend that, uh, we didn't talk about that I, that I seen, that I've noticed from speaking with, uh, people, uh, in the industry, is that because of the pandemic, our countries are changing their laws. Just last week, I received the new law of Panama, the Republic of Panama, because I'm working with a distributor that, um, is involved in setting up what the law says. And that law specifically says, for now on, we're gonna have a national, nationwide telemedicine system. And this law just passed a few months ago, and they have a year to implement this. So other countries in Latin America are adapting to this. And this is all because of the pandemic.
Speaker 3:That is correct. Digital health. People are seeing digital health as, as the, the solution of not finding ourself in the same predicament, the same situation we did. I mean, at least I'm very glad that the people leading the countries, uh, got shook up to the point that they say, this cannot happen again. We need to do something. I, I, I pray Panama for taking that step. I mean, that's a, a wonderful vision. Uh, I hope that the rest of the, of, of the countries in Latin America, see, see this, we got the same thing from Germany, for example. Such a conservative country, right? Basically pass a law saying digital health is the mission for the country. We're pushing this. We're giving the doctors the, the, the power to prescribe digital health. The prescribe devices, prescribe the, the memberships of, of, of, uh, of having the service for telemedicine and, and remote care, remote patient care. Uh, the US also did that. I mean, so, so for Panama to be in, in, in those countries that take the first step. I mean, my, my, my hat's off. I, I, I'm so happy. I'm so happy to see that. You see, we are, we are, we are growing, we're growing. The area is growing and understanding that we can, that can take those bold decisions. We don't need to wait for anybody else in the world to take them. We can take those bold decisions and move forward.
Speaker 2:Like, I, I like to say, uh, we are upgrading our thinking as a region.
Speaker 3:You got that. You got that right. You got that right. You got that right. I wanna see, I wanna see Latin American 2.0 right now.
Speaker 2:<laugh> 2.0 be, I'm gonna use that. Gonna steal that from you.
Speaker 3:America
Speaker 2:Podcast America 2.0.
Speaker 3:We're gonna make a mark. We're gonna make a mark<laugh>.
Speaker 2:All right, Widy, we're close to the end of the show, but, uh, before we close, uh, tell us about your plans. What traction are you getting in Latin America? What plans you have? Are you talking to distributors? When are you planning to start selling or getting regulatory approvals in different countries and
Speaker 3:All that? Definitely, definitely. We are, we, we are creating that plan. So I can, I can only tell you that we are super focused in, in, uh, Latin America as a choice. Um, we are, we're making sure that we are getting, um, all of the, all of the, um, requirements and certifications that will allow us to convert to the local certifications. For example, with this UL and this, this fda, we know that we will easily go and, and go into the, the Indian pack countries that we can go, uh, further south into, into Hawaii, Argentina, the rest of the countries. You know, we know that once we get that our path forward is going to be smoother. At the same time as a company, we're looking for, for, um, um, people that know the market, that understand the market, that are willing to, to promote a product like ours and push it inside those markets. So, so we're open to have conversations with, um, local distributors that, that want to talk to us. Uh, um, they can contact me directly. Uh, I'm, I'm, you know, I'm, I'm very accessible for this because it is the main mission. Um, and yeah, we're, we want to start those conversations. Um, and as the lead of the company, I am committed to making sure that this product is available for my Latin American community. That you serve that so much. Very
Speaker 2:Good. Very good. Very good. Excellent, Willie. So it's been a, a great conversation. Same here. You, thank you again, of course. For being the show today. How can people get in contact with you?
Speaker 3:Um, they can go directly to our webpages as www dot teles. That's with an x@theend.com. Um, and, and from there, all of our contact information, it's, uh, it's good. The same thing with, uh, LinkedIn. We have a channel there. We also have a YouTube channel, and I think that, uh, Twitter and Facebook. So we are trying to spread the message of the company. Um, we want to make it accessible for people. We want people to know what we're doing. We don't want to come up as a surprise in the market one day. We want people to get involved and know our names. So when we come out there, um, we are a familiar face, right. And that they trust us with, uh, being part of their healthcare solutions at a family and personal level.
Speaker 2:<laugh>, and you just got your first round of funding, so you're ready to roll.
Speaker 3:I'm super excited. We're ready to roll. We, we have, uh, a lot of work to do. That gives me an immense level of responsibility to my investors, making sure that we have that ROI from them. But not only that, but that we can definitely also work with the founding team and get them to see this happening. Right. Everybody's excited.
Speaker 2:Excellent, witty. All right. Beautiful.
Speaker 3:Thank you so much, Leo.
Speaker 2:<laugh>. Bye.
Speaker 3:Bye. Bye.